Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Equity Average (2022 - 2025)

Envoy Medical's Equity Average history spans 4 years, with the latest figure at -$9.9 million for Q4 2025.

  • Quarterly results put Equity Average at -$9.9 million for Q4 2025, up 46.99% from a year ago — trailing twelve months through Dec 2025 was -$9.9 million (up 46.99% YoY), and the annual figure for FY2025 was -$15.5 million, down 50.35%.
  • Equity Average for Q4 2025 was -$9.9 million at Envoy Medical, up from -$18.8 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $1.5 million in Q4 2023 to a low of -$46.3 million in Q2 2023.
  • The 4-year median for Equity Average is -$20.2 million (2023), against an average of -$21.0 million.
  • The sharpest move saw Equity Average soared 104.88% in 2023, then crashed 1342.03% in 2024.
  • Year by year, Equity Average stood at -$30.9 million in 2022, then soared by 104.88% to $1.5 million in 2023, then crashed by 1342.03% to -$18.7 million in 2024, then surged by 46.99% to -$9.9 million in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at -$9.9 million, -$18.8 million, and -$27.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.